Stuart Johnson, MD, FIDSA, DTM&H

Medicine

Infectious Disease
Professor

Languages Spoken

English, Thai

Clinical Expertise

  • Clostridium Difficile Infection
  • General Infectious Disease
  • Infection Complications in Surgery
  • Travel-Related Infection
  • Tuberculosis (TB)

About Dr. Johnson

Interests
Foreign movies, Travel, Hiking

Medical Education

Medical School
University of Minnesota Medical School
Residency
University of Minnesota Hospital and Clinics - Internal Medicine: General
Fellowship
University of Minnesota Hospital and Clinics/VA Medical Center, Minneapolis - Infectious Diseases

Board Certification

Internal Medicine
American Board of

Research

  • Induction of antitoxin responses in Clostridium-difficile-infected patients compared to healthy blood donors von Eichel-Streiber, A.; Paik, W.; Knight, K.; Gisch, K.; Nadjafi, K.; Decker, C.; Bosnjak, O.; Cheknis, A.; Johnson, S.; von Eichel-Streiber, C., Anaerobe
  • Potential Risks and Rewards With Prophylaxis for Clostridium difficile Infection Johnson, S., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • A US Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile Associated Diarrheal Isolates and their Susceptibility to Fidaxomicin Snydman, D. R.; McDermott, L. A.; Jacobus, N. V.; Thorpe, C.; Stone, S.; Jenkins, S. G.; Goldstein, E. J.; Patel, R.; Forbes, B. A.; Mirrett, S.; Johnson, S.; Gerding, D. N., Antimicrobial Agents and Chemotherapy
View All ResearchShow Less
  • Clostridium difficile Infection (CDI) Severity and Outcome among Patients Infected with the NAP1/BI/027 Strain in a Non-Epidemic Setting Scardina, T.; Labuszewski, L.; Pacheco, S. M.; Adams, W.; Schreckenberger, P.; Johnson, S., INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
  • Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection (CDI) with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027, Wieczorkiewicz, J. T.; Lopansri, B. K.; Cheknis, A.; Osmolski, J. R.; Hecht, D. W.; Gerding, D. N.; Johnson, S., Antimicrobial Agents and Chemotherapy
  • Pathway to Prevention of Nosocomial Clostridium difficile Infection Goldstein, E. J.; Johnson, S.; Maziade, P. J.; McFarland, L. V.; Trick, W.; Dresser, L.; Millette, M.; Mazloum, H.; Low, D. E., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • Prevention of Clostridium difficile Infection With Probiotics Evans, C. T.; Johnson, S., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • Real-Time Polymerase Chain Reaction Detection of Angiostrongylus cantonensis DNA in Cerebrospinal Fluid from Patients with Eosinophilic Meningitis Qvarnstrom, Y.; Xayavong, M.; Aramburu da Silva, A. C.; Park, S. Y.; Whelen, A. C.; Calimlim, P. S.; Sciulli, R. H.; Honda, S. A.; Higa, K.; Kitsutani, P.; Chea, N.; Heng, S.; Johnson, S.; Graeff-Teixeira, C.; Fox, L. M.; da Silva, A. J., The American Journal of Tropical Medicine and Hygiene
  • Treatment of Clostridium Difficile Infections Soriano, M. M.; Johnson, S., INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
  • Clostridium difficile binary toxin CDT: mechanism epidemiology, and potential clinical importance, Gerding, D. N.; Johnson, S.; Rupnik, M.; Aktories, K., Gut microbes
  • Community-Associated Clostridium difficile Infection among Veterans with Spinal Cord Injury and Disorder Balbale, S. N.; Johnson, S.; Burns, S. P.; Kralovic, S. M.; Goldstein, B.; Gerding, D. N.; Evans, C. T., Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America
  • Editorial commentary: Changing epidemiology of Clostridium difficile and emergence of new virulent strains Johnson, S., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • Enteric infections Wang, M.; Johnson, S., Cancer treatment and research
  • International typing study of Clostridium difficile Manzo, C. E.; Merrigan, M. M.; Johnson, S.; Gerding, D. N.; Riley, T. V.; Silva, J., Jr; Brazier, J. S.; International Clostridium difficile Study Group, Anaerobe
  • Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies Soriano, M. M.; Danziger, L. H.; Gerding, D. N.; Johnson, S., Open forum infectious diseases
  • Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder Ramanathan, S.; Johnson, S.; Burns, S. P.; Kralovic, S. M.; Goldstein, B.; Smith, B.; Gerding, D. N.; Evans, C. T., American Journal of Infection Control
  • Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin Bonchak, J. G.; Eby, J. M.; Willenborg, K. A.; Chrobak, D.; Henning, S. W.; Krzywiec, A.; Johnson, S. L.; Le Poole, I. C., ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
  • Vancomycin metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials, Johnson, S.; Louie, T. J.; Gerding, D. N.; Cornely, O. A.; Chasan-Taber, S.; Fitts, D.; Gelone, S. P.; Broom, C.; Davidson, D. M.; Polymer Alternative for CDI Treatment (PACT) investigators, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • Clostridium difficile infection and limitations of markers for severity in patients with hematologic malignancy Wang, M. S.; Evans, C. T.; Rodriguez, T.; Gerding, D. N.; Johnson, S., Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America
  • Editorial Commentary: Does Infection With Specific Clostridium difficile Strains or Clades Influence Clinical Outcome? Gerding, D. N.; Johnson, S., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • Important clinical advances in the understanding of Clostridium difficile infection Pacheco, S. M.; Johnson, S., CURRENT OPINION IN GASTROENTEROLOGY
  • Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Petrella, L. A.; Sambol, S. P.; Cheknis, A.; Nagaro, K.; Kean, Y.; Sears, P. S.; Babakhani, F.; Johnson, S.; Gerding, D. N., Clinical Infectious Diseases
  • Meeting the challenge of recurrent Clostridium difficile infection Johnson, S., Journal of Hospital Medicine
  • Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Figueroa, I.; Johnson, S.; Sambol, S. P.; Goldstein, E. J.; Citron, D. M.; Gerding, D. N., Clinical Infectious Diseases
  • Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative toxin B-positive clostridium difficile but does not prevent colonization., Siddiqui, F.; O'Connor, J. R.; Nagaro, K.; Cheknis, A.; Sambol, S. P.; Vedantam, G.; Gerding, D. N.; Johnson, S., Journal of Infectious Diseases
  • Clostridium difficile infection in 2010: advances in pathogenesis diagnosis and management of CDI, Gerding, D. N.; Johnson, Stuart, Nature Reviews Gastroenterology & Hepatology
  • Clostridium difficile infection rates and spectrum of disease among peripartum women at one hospital from 2003 to 2007 with molecular typing analysis of recovered Clostridium difficile isolates Venugopal, A. A.; Gerding, D. N.; Johnson, S., American Journal of Infection Control
  • Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Jabbar, U.; Leischner, J.; Kasper, D.; Gerber, R.; Sambol, S. P.; Parada, J. P.; Johnson, S.; Gerding, D. N., Infection Control & Hospital Epidemiology
  • Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. Merrigan, M.; Venugopal, A.; Mallozzi, M.; Roxas, B.; Viswanathan, V. K.; Johnson, S.; Gerding, D. N.; Vedantam, G., Journal of Bacteriology
  • Management of Clostridium difficile infection: thinking inside and outside the box Gerding, D. N.; Johnson, S., Clinical Infectious Diseases
  • Distribution of Clostridium difficile strains from a North American European and Australian trial of treatment for C. difficile infections: 2005-2007., Cheknis, A. K.; Sambol, S. P.; Davidson, D. M.; Nagaro, K. J.; Mancini, M. C.; Hidalgo-Arroyo, G. A.; Brazier, J. S.; Johnson, S.; Gerding, D. N., Anaerobe
  • Recurrent Clostridium difficile infection: a review of risk factors treatments, and outcomes, Johnson, S., Journal of Infection
  • Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment. Johnson, S.; Schriever, C.; Patel, U.; Patel, T.; Hecht, D. W.; Gerding, D. N., Anaerobe
  • Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat. Andrews, E. M.; Tsai, S. Y.; Johnson, S. C.; Farrer, J. R.; Wagner, J. P.; Kopen, G. C.; Kartje, G. L., Experimental neurology
  • Misestimation of peer tobacco use: understanding disparities in tobacco use Edwards, C. L.; Bennett, G. G.; Wolin, K. Y.; Johnson, S.; Fowler, S.; Whitfield, K. E.; Askew, S.; MacKinnon, D.; McDougald, C.; Hubbard, R.; Wellington, C.; Feliu, M.; Robinson, E., Journal of the National Medical Association
  • Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile. O'Connor, J. R.; Galang, M. A.; Sambol, S. P.; Hecht, D. W.; Vedantam, G.; Gerding, D. N.; Johnson, S., Antimicrobial Agents & Chemotherapy
  • Association of MC3R with body mass index in African Americans. Matsuoka, N.; Patki, A.; Tiwari, H. K.; Luke, A.; Wu, X.; Johnson, S. B.; Gregersen, P. K.; Allison, D. B.; Leibel, R. L.; Chung, W. K., International journal of body composition research
  • In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004. Hecht, D. W.; Galang, M. A.; Sambol, S. P.; Osmolski, J. R.; Johnson, S.; Gerding, D. N., Antimicrobial Agents & Chemotherapy
  • Infection of hamsters with historical and epidemic BI types of Clostridium difficile. Razaq, N.; Sambol, S.; Nagaro, K.; Zukowski, W.; Cheknis, A.; Johnson, S.; Gerding, D. N., Journal of Infectious Diseases
  • Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Johnson, S.; Schriever, C.; Galang, M.; Kelly, C. P.; Gerding, D. N., Clinical Infectious Diseases
  • Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital. Chang, H. T.; Krezolek, D.; Johnson, S.; Parada, J. P.; Evans, C. T.; Gerding, D. N., Infection Control & Hospital Epidemiology
  • Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system.[see comment] Belmares, J.; Gerding, D. N.; Parada, J. P.; Miskevics, S.; Weaver, F.; Johnson, S., Journal of Infection
  • Tuberculous tenosynovitis. Aboudola, S.; Sienko, A.; Carey, R. B.; Johnson, S., Human pathology